Back to top
more

Tabula Rasa Healthcare Inc. (TRHC)

(Delayed Data from NSDQ)

$55.29 USD

55.29
233,468

+2.12 (3.99%)

Updated May 3, 2019 04:00 PM ET

After-Market: $55.17 (%) 5:22 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

NA Value NA Growth NA Momentum NA VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

NA

Industry: NA

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Tabula Rasa Healthcare (TRHC) Reports Q4 Loss, Tops Revenue Estimates

by Zacks Equity Research

Tabula Rasa Healthcare (TRHC) delivered earnings and revenue surprises of -28.57% and 0.76%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

Are Options Traders Betting on a Big Move in Tabula Rasa HealthCare (TRHC) Stock?

by Zacks Equity Research

Investors need to pay close attention to Tabula Rasa HealthCare (TRHC) stock based on the movements in the options market lately.

Tabula Rasa Healthcare (TRHC) Reports Q3 Loss, Lags Revenue Estimates

by Zacks Equity Research

Tabula Rasa Healthcare (TRHC) delivered earnings and revenue surprises of -166.67% and -2.10%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?

Tabula Rasa Healthcare (TRHC) Reports Next Week: Wall Street Expects Earnings Growth

by Zacks Equity Research

Tabula Rasa Healthcare (TRHC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Tabula Rasa Healthcare (TRHC) Reports Q2 Loss, Tops Revenue Estimates

by Zacks Equity Research

Tabula Rasa Healthcare (TRHC) delivered earnings and revenue surprises of -200.00% and 1.00%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

Analysts Estimate Tabula Rasa Healthcare (TRHC) to Report a Decline in Earnings: What to Look Out for

by Zacks Equity Research

Tabula Rasa Healthcare (TRHC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Debanjana Dey headshot

MedTech Thrives on Healthcare IT in 2021: 4 Stocks to Focus on

by Debanjana Dey

Health IT stocks like HealthEquity (HQY), Veeva Systems (VEEV), Tabula Rasa (TRHC) and Allscripts (MDRX) are expected to continue their run over the next few months.

Tabula Rasa Healthcare (TRHC) Reports Q1 Loss, Tops Revenue Estimates

by Zacks Equity Research

Tabula Rasa Healthcare (TRHC) delivered earnings and revenue surprises of -28.57% and 0.67%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?

Analysts Estimate Tabula Rasa Healthcare (TRHC) to Report a Decline in Earnings: What to Look Out for

by Zacks Equity Research

Tabula Rasa Healthcare (TRHC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

CPSI vs. TRHC: Which Stock Is the Better Value Option?

by Zacks Equity Research

CPSI vs. TRHC: Which Stock Is the Better Value Option?

Tabula Rasa Healthcare (TRHC) Reports Q3 Loss, Lags Revenue Estimates

by Zacks Equity Research

Tabula Rasa Healthcare (TRHC) delivered earnings and revenue surprises of -120.00% and -6.67%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?

NXGN or TRHC: Which Is the Better Value Stock Right Now?

by Zacks Equity Research

NXGN vs. TRHC: Which Stock Is the Better Value Option?

NXGN vs. TRHC: Which Stock Is the Better Value Option?

by Zacks Equity Research

NXGN vs. TRHC: Which Stock Is the Better Value Option?

NXGN vs. TRHC: Which Stock Should Value Investors Buy Now?

by Zacks Equity Research

NXGN vs. TRHC: Which Stock Is the Better Value Option?

Tabula Rasa Healthcare (TRHC) Q2 Earnings Top Estimates

by Zacks Equity Research

Tabula Rasa Healthcare (TRHC) delivered earnings and revenue surprises of 75.00% and -1.27%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?

Analysts Estimate Tabula Rasa Healthcare (TRHC) to Report a Decline in Earnings: What to Look Out for

by Zacks Equity Research

Tabula Rasa Healthcare (TRHC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

CERN vs. TRHC: Which Stock Should Value Investors Buy Now?

by Zacks Equity Research

CERN vs. TRHC: Which Stock Is the Better Value Option?

Tabula Rasa HealthCare (TRHC) in Focus: Stock Moves 5.2% Higher

by Zacks Equity Research

Tabula Rasa HealthCare (TRHC) saw a big move last session, as its shares jumped more than 5% on the day, amid huge volumes.

    CERN or TRHC: Which Is the Better Value Stock Right Now?

    by Zacks Equity Research

    CERN vs. TRHC: Which Stock Is the Better Value Option?

    HMSY or TRHC: Which Is the Better Value Stock Right Now?

    by Zacks Equity Research

    HMSY vs. TRHC: Which Stock Is the Better Value Option?

    Tabula Rasa Healthcare (TRHC) Q1 Earnings Match Estimates

    by Zacks Equity Research

    Tabula Rasa Healthcare (TRHC) delivered earnings and revenue surprises of 0.00% and 1.86%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?

    Tabula Rasa Healthcare (TRHC) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

    by Zacks Equity Research

    Tabula Rasa Healthcare (TRHC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

    CPSI vs. TRHC: Which Stock Should Value Investors Buy Now?

    by Zacks Equity Research

    CPSI vs. TRHC: Which Stock Is the Better Value Option?

    Why Tabula Rasa Healthcare (TRHC) is Poised to Beat Earnings Estimates Again

    by Zacks Equity Research

    Tabula Rasa Healthcare (TRHC) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

    Zacks.com featured highlights include: Ionis Pharmaceuticals, Aphria, Tabula Rasa Healthcare, InterDigital and Huron Consulting Group

    by Zacks Equity Research

    Zacks.com featured highlights include: Ionis Pharmaceuticals, Aphria, Tabula Rasa Healthcare, InterDigital and Huron Consulting Group